Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
Name / Ticker | Price | Zen Rating |
---|---|---|
$7.77 | A | |
$22.48 | A | |
$40.37 | A |